Vanessa Di Cataldo
Azienda Ospedaliero-Universitaria Careggi, University of Florence
Papers
5
Total Citations
130
H-Index
5
About
Vanessa Di Cataldo is a leading clinical researcher in the field of stereotactic body radiotherapy (SBRT) and robotic radiosurgery, with a particular focus on treating recurrent and oligometastatic cancers. Her work has been instrumental in expanding the applications of non-invasive, high-precision radiation techniques to challenging clinical scenarios. A key contribution is her investigation into robotic stereotactic retreatment for recurrent prostate cancer in previously irradiated patients, a study that has garnered 50 citations and provides a critical salvage option for this difficult-to-treat population. She also led the phase II ROCK trial, a landmark study exploring preoperative robotic radiosurgery for early breast cancer, which demonstrated the feasibility of treating a well-defined target before surgery. Beyond these, her research has significantly advanced the management of liver oligometastases from colorectal cancer and abdominal lymph node metastases, consistently showing the safety and efficacy of SBRT in these settings. With multiple papers exceeding 15 citations, Di Cataldo’s work is widely recognized for its clinical impact, offering new hope to patients with limited treatment options and helping to define the modern role of robotic radiosurgery in oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5